Aijaz Saima, Erskine Lynda, Jeffery Glen, Bhattacharya Shomi S, Votruba Marcela
Department of Molecular Genetics, Institute of Ophthalmology, London, United Kingdom.
Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1667-73. doi: 10.1167/iovs.03-1093.
Autosomal dominant optic atrophy (ADOA) is characterized by primary degeneration of retinal ganglion cells and atrophy of the optic nerve. The OPA1 gene encodes a 960-amino-acid protein. In the current study the temporal and spatial localization of OPA1 were examined in developing and adult murine ocular tissues and the adult human eye. Because the Bst/+ mouse has been postulated as a model of ADOA, the mOPA1 expression in the Bst/+ retina was also examined.
A polyclonal antibody generated against a C-terminal peptide of OPA1 was used to assess by immunohistochemistry the expression of mOPA1 in the wild-type embryonic and postnatal mouse ocular tissues and the Bst/+ retina. Western blot analyses of total proteins from a panel of adult human tissues were used to examine the expression of human OPA1, and spatial localization was assessed by immunohistochemistry.
The ocular expression of mOPA1 begins at E15 in the inner retina in a location corresponding to that of the subsequently developing ganglion cell layer (GCL) and peaks between postnatal day (P)0 and P1 in the retina and the optic nerve. There is a sharp decline in mOPA1 expression after P2, but it is expressed at a basal level until at least P12 in the GCL, inner plexiform layer (IPL), and inner nuclear layer (INL) of the retina as well as in the optic nerve. In the adult Bst/+ retina, mOPA1 is strongly expressed in the GCL and IPL and weakly in the INL. In the adult human eye, OPA1 is expressed in the GCL, IPL, INL, and outer plexiform layer (OPL) of the retina and in the optic nerve, where it is observed only in the myelinated region.
OPA1 is not restricted to the GCL of the mammalian retina, and its expression extends into the IPL, INL, and OPL. OPA1 is distinctly expressed in the myelinated region beyond the lamina cribrosa in the human optic nerve, whereas its expression is weaker in the mouse optic nerve. In the Bst/+ mouse retina, despite the structural defects, mOPA1 expression is comparable to that observed in the wild-type adult mouse retina. These observations suggest a wider role for OPA1 than previously anticipated.
常染色体显性遗传性视神经萎缩(ADOA)的特征是视网膜神经节细胞原发性变性和视神经萎缩。OPA1基因编码一种含960个氨基酸的蛋白质。在本研究中,我们检测了OPA1在发育中和成年小鼠眼组织以及成年人类眼中的时空定位。由于Bst/+小鼠被假定为ADOA模型,我们还检测了Bst/+视网膜中mOPA1的表达。
使用针对OPA1 C端肽段产生的多克隆抗体,通过免疫组织化学评估mOPA1在野生型胚胎期和出生后小鼠眼组织以及Bst/+视网膜中的表达。对一组成人组织的总蛋白进行蛋白质印迹分析,以检测人类OPA1的表达,并通过免疫组织化学评估其空间定位。
mOPA1在眼内的表达于胚胎第15天开始在内侧视网膜中出现,其位置与随后发育的神经节细胞层(GCL)相对应,并在出生后第0天至第1天在视网膜和视神经中达到峰值。出生后第2天之后,mOPA1表达急剧下降,但在视网膜的GCL、内网层(IPL)、内核层(INL)以及视神经中,其表达至少在出生后第12天之前维持在基础水平。在成年Bst/+视网膜中,mOPA1在GCL和IPL中强烈表达,在INL中弱表达。在成年人类眼中,OPA1在视网膜的GCL、IPL、INL和外网层(OPL)以及视神经中表达,且仅在有髓鞘区域观察到其表达。
OPA1不仅局限于哺乳动物视网膜的GCL,其表达还延伸至IPL、INL和OPL。OPA1在人类视神经筛板后的有髓鞘区域有明显表达,而在小鼠视神经中的表达较弱。在Bst/+小鼠视网膜中,尽管存在结构缺陷,但mOPA1的表达与野生型成年小鼠视网膜中的表达相当。这些观察结果表明OPA1的作用比之前预期的更为广泛。